While cannabis as medicine is not new, the healthcare provider’s venture into the cannabis industry may be a new journey for many. In state medical marijuana programs doctors are the people who “recommend” cannabis (presently there is no actual prescription for cannabis).

In recent years, cannabis, also known as marijuana, has become more prevalent and accepted in many societies around the world. With the legalization of cannabis for medical and recreational use in several states and countries, its consumption has significantly increased.

On July 23, 2024, the Association of Cannabinoid Specialists was proud to invite ACS President and Founder Jordan Tishler, MD back to the podium as he presented on an Overview of Minor Cannabinoids, Terpenes, and Potential Uses.

The Association of Cannabinoid Specialists (ACS) is an international non-profit organization of physicians and other health professionals specializing in using cannabis or cannabinoids, as appropriate, for the care and treatment of patients suffering from a range of debilitating conditions such as cancer, Crohn’s disease, AIDS, multiple sclerosis, Parkinson’s disease, epilepsy, autism, and post-traumatic stress disorder, and patients with terminal illnesses.

Over the years, I have had the privilege of caring for a multitude of patients turning to cannabis as a therapeutic option for anxiety, spanning from general anxiety disorder and situational anxiety to its role in managing PTSD and accompanying depression.

Recently President and Founder of the Association of Cannabinoid Specialists, Jordan Tishler, MD, was invited to participate in a panel at the Cannabis Regulators Association (CANNRA) 2024 External Stakeholder Meeting in Minneapolis, MN.

State medical cannabis programs are slowly failing.  They are failing largely because they don’t support patient care, neither from the patients’ perspective nor from the practitioners’. 

On June 18, 2024, the Association of Cannabinoid Specialists was proud to host the symposium “Communicating Cannabis Use Before Surgery”, featuring Deondra Asike, MD, double board certified in anesthesiology and pain medicine.  In this symposium, Dr. Asike discusses the risks associated with cannabis use before surgery.

As the utilization of cannabis transcends traditional boundaries, encompassing medical treatments, recreational indulgence, and wellness pursuits, the profound impact of THC and cannabinoids on gastrointestinal physiology is coming to light.